Cited by 110Chronic Kidney Disease and DiabetesElectrolyte and hormonal disordersIon Transport and Channel Regulation

Vasopressin and diabetes mellitus

Bankir, Lise, Bardoux, Pascale, Ahloulay, Mina·2001·Nephron

Abstract

In diabetes mellitus (DM), the urine flow rate is increased, and the fluid turnover in the body is accelerated because of the glucose-induced osmotic diuresis. On the other hand, plasma vasopressin (VP) is elevated in both type 1 and type 2 DM. This elevation seems to be due to a resetting of the osmostat. A high VP level is beneficial in the short term because it limits to some extent the amount of water required for the excretion of a markedly enhanced load of osmoles (mainly glucose). However, in the long run, it may have adverse effects by favoring the developement of diabetic nephropathy. VP has been shown in normal rats to induce kidney hypertrophy, glomerular hyperfiltration, and an increase in urinary albumin excretion (features also occurring in association in the period preceding diabetic nephropathy). Moreover, VP has been shown to participate in the progression of renal failure in rats with five-sixths reduction in renal mass. In recent studies, we have shown (1) that creatinine clearance, albuminuria and renal mass increased much less during experimental DM in Brattleboro rats unable to secrete VP than in their VP-replete Long-Evans controls, and (2) that albuminuria was prevented during experimental DM in Wistar rats when a VP nonpeptidic, highly selective V2 receptor antagonist was administered chronically for 9 weeks. Taken together, these results strongly suggest that VP plays a crucial role in the onset and aggravation of the renal complications of DM. The mechanisms by which VP exerts these adverse V2-dependent effects are not yet elucidated. They are most likely indirect and may involve several intermediate steps comprising VP-induced changes in the composition of the tubular fluid in the loop of Henle (due to solute recycling in the renal medulla associated with improved concentrating activity of the kidney), inhibition of the tubuloglomerular feedback control of glomerular function, and alterations in glomerular hemodynamics by the intrarenal renin-angiotensin system.

Integrity signals

Registry

Crossref · 10.1159/000045879

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Vasopressin receptors are expressed in hepatocytes and pancreatic islets.

    “A causal link between vasopressin and glucose homeostasis is plausible because vasopressin induces gluconeogenesis in the rat liver and transiently increases glycemia in healthy humans and because vasopressin receptors are expressed in hepatocytes and pancreatic islets (2–9).”

    From Low Water Intake and Risk for New-Onset Hyperglycemia (2011) · cites this paper as [3]

  • A causal link between vasopressin and glucose homeostasis is plausible.

    “A causal link between vasopressin and glucose homeostasis is plausible because vasopressin induces gluconeogenesis in the rat liver and transiently increases glycemia in healthy humans and because vasopressin receptors are expressed in hepatocytes and pancreatic islets (2–9).”

    From Low Water Intake and Risk for New-Onset Hyperglycemia (2011) · cites this paper as [3]

  • Vasopressin transiently increases glycemia in healthy humans.

    “A causal link between vasopressin and glucose homeostasis is plausible because vasopressin induces gluconeogenesis in the rat liver and transiently increases glycemia in healthy humans and because vasopressin receptors are expressed in hepatocytes and pancreatic islets (2–9).”

    From Low Water Intake and Risk for New-Onset Hyperglycemia (2011) · cites this paper as [3]

  • Vasopressin induces gluconeogenesis in the rat liver.

    “A causal link between vasopressin and glucose homeostasis is plausible because vasopressin induces gluconeogenesis in the rat liver and transiently increases glycemia in healthy humans and because vasopressin receptors are expressed in hepatocytes and pancreatic islets (2–9).”

    From Low Water Intake and Risk for New-Onset Hyperglycemia (2011) · cites this paper as [3]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Bankir, L., Bardoux, P., & Ahloulay, M.
Affiliations
Inserm (FR)
Venue
Nephron
Publisher
S. Karger AG
Published
2001
Volume
87
Issue
1
Pages
8-18
ISSN
  • 1660-8151 (ISSN-L)
  • 2235-3186
OpenAlex
W2037060198
Cited by
110
References
66
Citations by year
2026: 1 · 2025: 3 · 2024: 3 · 2023: 8 · 2022: 2 · 2021: 2 · 2020: 4 · 2019: 5 · 2018: 8 · 2017: 8 · 2016: 8 · 2015: 5 · 2014: 3 · 2013: 5 · 2012: 3
FWCI
3.60
Type
journal article
Language
en
Open access
closed
Locations
  • The Nephron journals/Nephron journals (publishedVersion)
  • PubMed (publishedVersion)
Funders
Institut National de la Santé et de la Recherche Médicale
Topics
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Electrolyte and hormonal disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion Transport and Channel Regulation
Keywords
vasopressin, diabetes mellitus, diabetic nephropathy, osmotic diuresis, vasopressin V2 receptor antagonist, albuminuria, renal hypertrophy, glomerular hyperfiltration, tubuloglomerular feedback, intrarenal renin-angiotensin system, loop of Henle, Brattleboro rats, Long-Evans rats
MeSH terms
Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Humans, Vasopressins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review